Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

"This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from 14th October 2019 to 18th October 2019," the company said in a BSE filing.

New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has cleared the inspection conducted by the US health regulator for its Bioequivalence Center located at Taloja, Maharashtra.

The facility was inspected from October 14 to October 18, 2019.

"This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from 14th October 2019 to 18th October 2019," the company said in a BSE filing.

Also Read: Alkem Labs gets 2 USFDA observations for Daman facility

"At the end of the inspection, no Form 483 was issued," Alkem added.

Established in 1973, Alkem Laboratories has a portfolio of over 700 brands covering all major therapeutic segments. It has 16 manufacturing facilities, 14 being in India and two in the United States.

Also Read: Alkem Labs gets 4 USFDA observations for St Louis facility